Inoue, Hiroto
Todaka, Akiko
Yamazaki, Kentaro
Fushiki, Kunihiro
Shirasu, Hiromichi
Kawakami, Takeshi
Tsushima, Takahiro
Hamauchi, Satoshi
Yokota, Tomoya
Machida, Nozomu
Fukutomi, Akira
Onozawa, Yusuke
Andoh, Akira
Yasui, Hirofumi
Article History
Received: 16 February 2021
Accepted: 9 March 2021
First Online: 9 April 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board of Shizuoka Cancer Center (reference number: J2019–180-2019-1-2) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: For this type of study, formal consent is not required.
: H Inoue declares that he has no conflict of interest. A Todaka declares that he has no conflict of interest. K Yamazki received honoraria from Taiho, Takeda, Chugai, Yakult, Ono, Bristol-Myers, Eli Lily, Merk, MSD, Bayer and Sanofi, and received a research funding from Taiho and Eli Lily. K Fushiki declares that he has no conflict of interest. H Shirasu declares that he has no conflict of interest. T Kawakami received honoraria from Taiho. T Tsushima declares that he has no conflict of interest. S Hamauchi declares that he has no conflict of interest. T Yokota declares that he has no conflict of interest. N Machida declares that he has no conflict of interest. A Fukutomi declares that he has no conflict of interest. Y Onozawa declares that he has no conflict of interest. A Ando declares that he has no conflict of interest. H Yasui declares that he has no conflict of interest.